This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Yu Qiu in FGFR3 Antibodies
Introduction
Yu Qiu is an accomplished inventor based in Framingham, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of FGFR3 antibodies. Her work focuses on creating anti-FGFR3 antigen-binding proteins and methods for treating FGFR3-mediated diseases.
Latest Patents
Yu Qiu holds a patent for FGFR3 antibodies and methods of use. This patent includes anti-FGFR3 antigen-binding proteins and their binding fragments. Additionally, it outlines methods for inhibiting FGFR3 activity and treating diseases associated with FGFR3.
Career Highlights
Yu Qiu is currently employed at Genzyme Corporation, where she continues to advance her research in biotechnology. Her innovative work has the potential to impact various medical treatments and improve patient outcomes.
Collaborations
Some of her notable coworkers include Yves Sabbagh and Yangde Chen, who contribute to her research efforts at Genzyme Corporation.
Conclusion
Yu Qiu's contributions to the field of FGFR3 antibodies exemplify her dedication to innovation in biotechnology. Her work not only enhances our understanding of FGFR3-mediated diseases but also paves the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile